EX-10.1



 Exhibit 10.1 

EMPLOYMENT AGREEMENT 

This AGREEMENT, dated April 14, 2015 (the “Agreement”), by and among Surgical Care Affiliates, Inc. (the
“Parent”), Surgical Care Affiliates LLC (the “Employer” and together with the Parent, the “Company”) and Tom W. F. De Weerdt (the “Executive”). 

WHEREAS, the Company desires that the Executive serve the Company as its Executive Vice President and Chief Financial Officer on the terms and
conditions set forth herein. 
 NOW, THEREFORE, in consideration of the premises and mutual covenants herein and for other good and valuable
consideration, the parties agree as follows: 
 1. Employment, Duties and Agreements. 

(a) The Company hereby agrees to employ the Executive as its Executive Vice President and Chief Financial Officer, and the Executive hereby
accepts such position and agrees to serve the Company in such capacity during the employment period fixed by Section 3 hereof (the “Employment Period”). The Executive shall report to the Chief Executive Officer of the Company
or its designee and shall have such duties and responsibilities as are consistent with the Executive’s position. During the Employment Period, the Executive shall be subject to, and shall act in accordance with, all reasonable instructions and
directions, and all applicable policies and rules, of the Company, including without limitation any policy with respect to equity hedging. The Executive’s principal work location shall be at the Company’s offices in Deerfield, IL, or such
other location as the Executive and the Company shall mutually agree, (hereinafter the “Principal Place of Business”) provided that the Executive may be required to travel as necessary in order to perform his duties and
responsibilities hereunder. 
 (b) During the Employment Period, excluding any periods of vacation and sick leave to which the Executive is
entitled, the Executive shall devote his full working time, energy and attention to the performance of his duties and responsibilities hereunder and shall faithfully and diligently endeavor to promote the business and best interests of the Company.

 (c) During the Employment Period, the Executive may not, without the prior written consent of the Board of Directors of the Parent (the
“Board”), which consent shall not be unreasonably withheld, directly or indirectly, operate, participate in the management, operations or control of, or act as an executive, officer, consultant, agent or representative of, any type
of business or service (other than as an executive of the Company), provided that it shall not be a violation of the foregoing for the Executive to (i) continue to serve on the board of another company of which the Executive is currently
serving, as set forth on Exhibit A hereto, provided that such companies are not competitors of the Company; (ii) serve on the board of directors of trade associations and/or charitable organizations; (iii) engage in charitable
activities and community affairs; and (iv) manage his personal investments and affairs; provided that the activities described in the preceding clauses (i) through (iv) do not interfere with the proper performance of his duties
and responsibilities hereunder. 
 2. Compensation. 

(a) As compensation for the agreements made by the Executive herein and the performance by the Executive of his obligations hereunder, during
the Employment Period, the Employer shall pay the Executive, pursuant to the Employer’s normal and customary payroll procedures, a base salary at the rate of $425,000 per annum, (the “Base Salary”), subject to annual review and
increases as determined by the Board in its discretion. 







 (b) In addition to the Base Salary, during the Employment Period, the Executive shall be eligible
to participate in the executive bonus program (the “Program”), to be established and approved by the Board from time to time and, pursuant to the Program, the Executive may earn an annual bonus (the “Annual Bonus”)
in each fiscal year during the Employment Period, with a target Annual Bonus of 65% of Base Salary up to a maximum of 130% of Base Salary, based on the achievement of annual performance objectives as set forth in the Program, subject to the
Executive’s employment with the Company through the applicable payment date for any such Annual Bonus (except as otherwise provided herein). Annual Bonuses shall be paid as soon as practicable following the end of the fiscal year to which such
Annual Bonus relates, and in any event no later than March 31 of the year following such fiscal year. Notwithstanding the foregoing, for the fiscal year 2015 only (i.e., for the bonus payment made in March 2016), the Executive’s Annual
Bonus shall be in the amount of $276,250. 
 (c) On the Effective Date (as defined in Section 3 below), the Parent will grant the
Executive the number of restricted stock units with a fair market value equal to $800,000 (the “2015 RSU Grant”), as such value is determined as of the date of the grant pursuant to the Surgical Care Affiliates, Inc. 2013 Omnibus Long-Term
Incentive Plan, as amended (the “Plan”). The specific terms and conditions governing all aspects of the 2015 RSU Grant shall be consistent with the Plan and as set forth in the form of Restricted Stock Unit Award Agreement attached hereto
as Exhibit B, which shall be executed by the Executive as a condition of the effectiveness of the grant described herein. In March 2016, if the Executive is still employed by the Company at that time, the Parent will issue an equity grant to
the Executive with a fair market value equal to approximately $600,000 (the “2016 Equity Grant”), as such value is determined as of the date of the grant pursuant to the Plan. The 2016 Equity Grant may be in the form of options, RSUs
and/or performance stock units, at the sole discretion of the Compensation Committee of the Board of Directors of the Parent, and the vesting provisions and other terms of the 2016 Equity Grant shall be consistent with those for the equity grants
made to other Executive Vice Presidents of the Company in March 2016. Thereafter during the Employment Period, the Executive shall be eligible to participate in the equity or equity-based incentive plans of the Parent as may be established by the
Board from time to time, subject to the terms and conditions thereof. 
 (d) During the Employment Period, the Executive and his eligible
dependents shall be entitled to participate in all welfare benefit and savings and retirement plans, practices, policies and programs of the Employer (including the Employer’s health insurance and disability plans) provided by the Employer
which are made available generally to other executive officers of the Company (for the avoidance of doubt, such plans, practices, policies or programs shall not include any plan, practice, policy or program which provides benefits in the nature of
severance or continuation pay). 
 (e) The Employer shall reimburse the Executive for all reasonable business expenses upon the presentation
of statements of such expenses in accordance with the Company’s policies and procedures now in force or as such policies and procedures may be modified with respect to all senior executive officers of the Company. 

(f) Within fourteen (14) days after the Effective Date (as defined in Section 3 below), the Employer shall pay the Executive a cash
signing bonus in the amount of $200,000 (subject to employment tax withholdings). 
 3. Employment Period. 

The Employment Period shall be effective as of May 19, 2015 (the “Effective Date”) and shall terminate on the third
anniversary of the Effective Date, provided that on the third anniversary of the Effective Date and on each anniversary thereafter, the Employment Period shall automatically be extended for additional one-year periods unless either party provides
the other party with notice of non-

  
 2 








 
renewal at least ninety (90) days before any such anniversary (the anniversary date on which the Employment Period terminates shall be referred to herein as the “Scheduled
Termination Date”). Notwithstanding the foregoing, the Executive’s employment hereunder may be terminated during the Employment Period prior to the Scheduled Termination Date upon the earliest to occur of the following events (at which
time the Employment Period shall be terminated): 
 (a) Death. The Executive’s employment hereunder shall terminate upon his
death. 
 (b) Disability. The Company shall be entitled to terminate the Executive’s employment hereunder for
“Disability” if, as a result of the Executive’s incapacity due to physical or mental illness or injury, the Executive (i) shall become eligible to receive a benefit under the Company’s long-term disability plan applicable to
the Executive, or (ii) the Executive has been unable, due to physical or mental illness or incapacity, to perform the essential duties of his employment with reasonable accommodation for a continuous period of 90 days or an aggregate of 180
days. 
 (c) Cause. The Company may terminate the Executive’s employment hereunder for Cause. For purposes of this Agreement,
the term “Cause” shall mean: (i) the Executive’s act of fraud, misappropriation, or embezzlement with respect to the Company; (ii) the Executive’s indictment for, conviction of, or plea of guilty or no contest
to, any felony; (iii) the suspension or debarment of the Executive or of the Company or any of its affiliated companies or entities as a direct result of any act or omission of the Executive in connection with his employment with the Company
from participation in any Federal or state health care program; (iv) the Executive’s admission of liability of, or finding of liability for, the willful violation of any “Securities Laws” (as hereinafter defined); (v) the
Executive’s repeated failure after reasonable prior written notice to comply with any valid and legal directive of the Chief Executive Officer or the Board; or (vi) other than as provided in Sections 3(c)(i)-(v) above, the
Executive’s breach of any material provision of this Agreement that is not remedied within fifteen (15) days of the Executive being provided written notice thereof from the Company. Repeated breaches of a similar nature, such as the
failure to report to work, perform duties, or follow directions, all as provided herein, shall not require additional notices pursuant to Section 3(c)(vi). As used herein, the term “Securities Laws” means any Federal or state
law, rule or regulation governing the issuance or exchange of securities, including without limitation the Securities Act of 1933, the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder. 

(d) Without Cause. The Company may terminate the Executive’s employment hereunder during the Employment Period without Cause,
which shall include the Company providing notice of non-renewal of this Agreement prior to any Scheduled Termination Date pursuant to and in accordance with Section 3 hereof. 

(e) For Good Reason. The Executive may terminate this Agreement at any time upon sixty (60) days’ prior written notice to the
Company and the Company fails to cure such event within such sixty (60)-day period (any such termination referenced in clauses (i)-(v) below, unless the Executive shall have consented in writing thereto, constituting termination for
“Good Reason”): (i) if the Company fails to make all or any portion of any payment required by Sections 2(a) and (b) hereof within a reasonable time after such payments are due; (ii) if the Company materially modifies
the Program such that the targeted cash bonus levels described in Section 2(b) herein and applicable to the Executive are lower than those levels of other similarly-situated executive officers of the Company; (iii) upon a material
diminution of the Executive’s duties, responsibilities or positions, including without limitation an adverse change to his reporting relationships as set forth in Section 1(a) of this Agreement; (iv) the relocation of the
Executive’s work location set forth in Section 1(a) more than fifty (50) miles from the Principal Place of Business; and/or (v) except as otherwise set forth in clauses (i) through (iv) above, if the Company materially
breaches any of its other duties or obligations hereunder. 

  
 3 








 (f) Voluntarily. The Executive may voluntarily terminate his employment hereunder (other
than for Good Reason), provided that the Executive provides the Company with notice of his intent to terminate his employment at least sixty (60) days in advance of the Date of Termination (as defined in Section 4 below). 

4. Termination Procedure. 

(a) Notice of Termination. Any termination of the Executive’s employment by the Company or by the Executive during the Employment
Period (other than a termination on account of the death of Executive) shall be communicated by written “Notice of Termination” to the other party hereto in accordance with Section 12(a). 

(b) Date of Termination. “Date of Termination” shall mean (i) if the Executive’s employment is terminated by
his death, the date of his death, (ii) if the Executive’s employment is terminated pursuant to Section 3(b), on the date the Executive receives Notice of Termination from the Company, (iii) if the Executive voluntarily terminates
his employment (including for Good Reason), the date specified in the notice given pursuant to Section 3(e) or (f) herein, as applicable, which shall not be less than sixty (60) days after the Notice of Termination, and (iv) if
the Executive’s employment is terminated for any other reason, the date on which a Notice of Termination is given or any later date (within thirty (30) days, or any alternative time period agreed upon by the parties, after the giving of
such notice) set forth in such Notice of Termination; provided, that, the Company may terminate the Executive’s employment at any time for Cause. 

5. Termination Payments. 

(a) Without Cause or for Good Reason. In the event of the termination of the Executive’s employment during the Employment Period
(i) by the Company without Cause, (ii) by the Executive for Good Reason or (iii) if the Company provides a notice of non-renewal of the Employment Period under Section 3, by the Executive or the Company for any reason effective
at any time on or after the Scheduled Termination Date, and in each case other than a CIC Termination described in Section 5(d), during the eighteen (18) months following the Date of Termination (the “Salary Continuation
Period”) the Executive shall receive, in addition to his accrued but unused vacation and Base Salary through the Date of Termination and any Annual Bonus in respect of the prior fiscal year (to the extent earned but not theretofore paid),
salary continuation payments paid in accordance with the Company’s normal and customary payroll practices at the same rate as the Executive’s annual Base Salary. On the date that bonuses are otherwise paid to participants in the Program, a
single lump sum payment will be payable equal to the Executive’s Annual Bonus, based upon achievement of performance objectives as set forth in the Program, multiplied by a fraction, the numerator of which is the number of full weeks in the
period beginning on the first day of the then-current annual performance period and ending on the Date of Termination and the denominator of which is fifty two (the “Pro Rata Bonus”). In addition, during the eighteen (18) month
period following the Date of Termination, the Company shall continue to provide medical benefits to the Executive which are (and on terms which are) substantially similar to those provided generally to executive officers of the Company pursuant to
such medical plan as may be in effect from time to time (it being understood that the Company may provide such coverage by paying the Executive’s COBRA premiums, less any contribution required by the Executive consistent with the contributions
required of similarly situated executives who continue to be employed by the Company); provided, however, that if the Executive becomes re-employed with another employer and is eligible to receive health insurance benefits under another
employer provided plan, the Executive is obligated to promptly notify the Company of any changes in his benefits coverage and the Company reimbursements described herein shall terminate (the “Continued Healthcare Benefit”). The
Executive also shall be entitled to reimbursement of any and all reasonable business expenses incurred in connection with the 

  
 4 








 
Executive’s duties and responsibilities under this Agreement in accordance with Company policy, to the extent not previously reimbursed. The salary continuation payments, the Pro Rata Bonus
and reimbursement for COBRA (as such term is defined below) continuation coverage are subject to and conditioned upon the Executive executing a valid general release and waiver (in the form acceptable to the Company), waiving all claims the
Executive may have against the Company, its successors, assigns, affiliates, executives, officers and directors, and such waiver becoming effective on or before the thirtieth (30th) day
following the Date of Termination, and the payments and benefits are subject to and conditioned upon the Executive’s compliance with the Restrictive Covenants provided in Sections 7 and 8 hereof (together, the “Conditions”).
Except as set forth herein, the Executive shall not be required to mitigate any damages that the Executive may incur as a result of a termination of his employment by the Company without Cause or for Good Reason during the Employment Period. Except
as provided in this Section 5(a), and except for any vested benefits under any tax qualified pension plans of the Company, and continuation of health insurance benefits on the terms and to the extent required by Section 4980B of the
Internal Revenue Code of 1986, as amended (“Code”) and Section 601 of the Employee Retirement Income Security Act of 1974, as amended (which provisions are commonly known as “COBRA”), the Company shall have no
additional obligations under this Agreement. 
 (b) Disability or Death. If the Executive’s employment is terminated during the
Employment Period as a result of the Executive’s death or Disability, the Company shall pay the Executive or the Executive’s estate, as the case may be, within thirty (30) days following the Date of Termination: (i) the
Executive’s accrued but unused vacation; (ii) his accrued but unpaid Base Salary; (iii) any unpaid Annual Bonus earned by the Executive in respect of the fiscal year ending immediately prior to the Date of Termination; and
(iv) the Pro Rata Bonus (subject to, and conditioned upon, in the event the Executive’s employment terminated as a result of the Executive’s Disability, the Executive satisfying the Conditions). Except as provided in this
Section 5(b), and except for any vested benefits under any tax qualified pension plans of the Company, and continuation of health insurance benefits on the terms and to the extent required by COBRA, the Company shall have no additional
obligations under this Agreement. 
 (c) Cause or Voluntarily. If the Executive’s employment is terminated during the Employment
Period by the Company for Cause or voluntarily by the Executive other than for Good Reason, the Company shall pay the Executive within thirty (30) days following the Date of Termination: (i) the Executive’s accrued but unused vacation
through the Date of Termination; and (ii) his accrued but unpaid Base Salary through the Date of Termination. Except as provided in this Section 5(c) and except for any vested benefits under any tax qualified pension plans of the Company,
and continuation of health insurance benefits on the terms and to the extent required by COBRA, the Company shall have no additional obligations under this Agreement. 

(d) Change in Control Termination. In lieu of the payments and benefits described in Section 5(a) above, but subject to and
conditioned upon the Executive satisfying the Conditions, in the event the Executive’s employment is terminated (x) by the Company without Cause, (y) by the Executive for Good Reason or (z) if the Company provides a notice of
non-renewal of the Employment Period under Section 3, by the Executive or the Company for any reason effective at any time on or after the Scheduled Termination Date, and in each such case occurring within the three (3) months prior to the
consummation of, or within the twenty-four (24) month period following the occurrence of, a Change in Control (such termination, a “CIC Termination”), the Executive shall be entitled to, in addition to his accrued but unused
vacation and Base Salary through the Date of Termination and any Annual Bonus in respect of the prior fiscal year (to the extent earned but not theretofore paid), subject to the Executive satisfying the Conditions (i) an amount equal to one and
one-half times (1.5x) the sum of (A) the Executive’s then-current Base Salary and (B) the Executive’s target Annual Bonus, payable in a lump sum within forty (40) days following the date of such CIC Termination,
(ii) the Pro Rata Bonus, and (iii) the Continued 

  
 5 








 
Healthcare Benefit. For any such termination occurring prior to the consummation of a Change in Control, Section 5(a) shall apply upon such termination and upon the occurrence of the Change
in Control this Section 5(d) shall apply, with the payments and benefits due under this Section 5(d) reduced by the payments and benefits previously received under Section 5(a) through the date thereof. For purposes of this Agreement,
“Change in Control” shall mean a change in the ownership or effective control of the Company, or a change in the ownership of a substantial portion of the assets of the Company, within the meaning of Section 409A(a)(2)(A)(v) of
the Code and U.S. Treasury Regulation Section 1.409A-3(i)(5). Except as provided in this Section 5(d) and except for any vested benefits under any tax qualified pension plans of the Company, and continuation of health insurance benefits on
the terms and to the extent required by COBRA, the Company shall have no additional obligations under this Agreement. 
 6. Legal Fees;
Indemnification; Officers’ Liability Insurance. 
 (a) In the event of any contest or dispute between the Company and the Executive
with respect to this Agreement or the Executive’s employment hereunder, each of the parties shall be responsible for its respective legal fees and expenses; provided that in the event of any dispute between the Company and the Executive
that arises during the three (3) months preceding or at any time following the occurrence of a Change in Control, the Company shall be responsible for reimbursing the Executive for the Executive’s reasonable legal fees and expenses in the
event that the Executive prevails on at least one material issue central to the dispute in a final, non-appealable judgment of such dispute. 

(b) During the Employment Period and thereafter with regard to the Executive’s activities during the Employment Period on behalf of the
Company, its subsidiaries or affiliates, or as a fiduciary of any benefit plan of any of them, the Company shall indemnify the Executive to the fullest extent permitted by applicable law (other than in connection with the Executive’s gross
negligence or willful misconduct), and shall at the Company’s election provide the Executive with legal representation or shall advance to the Executive reasonable attorneys’ fees and expenses as such fees and expenses are incurred
(subject to an undertaking from the Executive to repay such advances if it shall be finally determined by a judicial decision which is not subject to further appeal that the Executive was not entitled to the reimbursement of such fees and expenses).
During the Employment Period, the Executive shall be entitled to the same directors’ and officers’ liability insurance coverage that the Company provides generally to its other directors and officers, as may be amended from time to time
for such directors and officers. 
 7. Non-Solicitation. 

During the Employment Period and for eighteen (18) months thereafter, the Executive hereby agrees not to, directly or indirectly, solicit
or assist any other Person (as defined below) in soliciting any employee of the Company or any of its affiliates to perform services for any entity (other than the Company or its affiliates), attempt to induce any such employee to leave the employ
of the Company or its affiliates, or hire or engage on behalf of himself or any other Person any employee of the Company or anyone who was employed by the Company during the six-month period preceding such hiring or engagement. An individual’s
response to a broad and general advertisement or solicitation not specifically targeting or intending to target employees of the Company, its subsidiaries or any of affiliates shall not be deemed a violation of this Section 7. 

8. Confidentiality; Non-Compete; Non-Disclosure; Non-Disparagement. 

(a) The Executive hereby agrees that, during the Employment Period and thereafter, he will hold in strict confidence any proprietary or
Confidential Information related to the Company and its affiliates. For purposes of this Agreement, the term “Confidential Information” shall mean all 

  
 6 








 
information of the Company or any of its affiliates (in whatever form) which is not generally known to the public, including without limitation any inventions, processes, methods of distribution,
customer lists or customers’ or trade secrets. 
 (b) The Executive and the Company agree that the Company would likely suffer
significant harm from the Executive’s competing with the Company during the Employment Period and for some period of time thereafter. Accordingly, the Executive agrees that he will not, during the Employment Period and for a period of eighteen
(18) months following the termination of the Employment Period for any reason, directly or indirectly, become employed by, engage in business with, serve as an agent or consultant to, become a partner, member, principal, stockholder or other
owner (other than a holder of less than 1% of the outstanding voting shares of any publicly held company) of, or otherwise perform services relating to, the Business (as defined below) for any Person that is engaged in, or otherwise competes or has
a reasonable potential for competing with the Business (as defined herein), anywhere in which the Company or its subsidiaries engage in or intend to engage in the Business or where the Company or its subsidiaries’ customers are located (whether
or not for compensation). For purposes of Sections 7 and 8, the term “Person” shall mean any individual, partnership, corporation, limited liability company, unincorporated organization, trust or joint venture, or a governmental
agency or political subdivision thereof. For purposes of Sections 7 and 8, the “Business” shall mean the operation and administration of a network of ambulatory surgical care centers or surgical hospitals providing facilities and
medical staff (with re-syndication of ownership interests by participating physicians). 
 (c) The Executive hereby agrees that upon the
termination of the Employment Period, he shall not take, without the prior written consent of the Company, any Confidential Information, including without limitation any business plans, contact lists, strategic plans or reports or other document (in
whatever form) of the Company or its affiliates, relating to its or their methods of distribution, or any description of any formulas or secret processes and will return any such information (in whatever form) then in his possession. 

(d) The Executive agrees not to defame or disparage the Company or its affiliates and their officers, directors, members or executives. The
Executive agrees to cooperate with the Company in refuting any defamatory or disparaging remarks by any third party made in respect of the Company or its affiliates or their directors, members, officers or executives. The Company agrees that its
Senior Vice Presidents, Executive Vice Presidents and President shall not in any way defame or disparage the Executive. 
 9. Injunctive
Relief. 
 It is impossible to measure in money the damages that will accrue to the Company in the event that the Executive breaches any
of the restrictive covenants provided in Sections 7 and 8 hereof. In the event that the Executive breaches any such restrictive covenant, the Company shall be entitled to an injunction restraining the Executive from violating such restrictive
covenant (without posting any bond). If the Company shall institute any action or proceeding to enforce any such restrictive covenant, the Executive hereby waives the claim or defense that the Company has an adequate remedy at law and agrees not to
assert in any such action or proceeding the claim or defense that the Company has an adequate remedy at law. The foregoing shall not prejudice the Company’s right to require the Executive to account for and pay over to the Company, and the
Executive hereby agrees to account for and pay over, the compensation, profits, monies, accruals or other benefits derived or received by the Executive as a result of any transaction constituting a breach of any of the restrictive covenants provided
in Sections 7 and 8 hereof. 

  
 7 








 10. Section 280G. 

Notwithstanding any other provision of this Agreement or any other plan, arrangement, or agreement to the contrary, if any of the payments or
benefits provided or to be provided by the Company or its affiliates to the Executive or for the Executive’s benefit pursuant to the terms of this Agreement or otherwise (“Covered Payments”) constitute parachute payments
(“Parachute Payments”) within the meaning of Section 280G of the Code and would, but for this Section 10, be subject to the excise tax imposed under Section 4999 of the Code (or any successor provision thereto) or any
similar tax imposed by state or local law or any interest or penalties with respect to such taxes (collectively, the “Excise Tax”), then the Covered Payments shall be payable either (i) in full or (ii) reduced to the
minimum extent necessary to ensure that no portion of the Covered Payments is subject to the Excise Tax, whichever of the foregoing (i) or (ii) results in the Executive’s receipt on an after-tax basis of the greatest amount of
benefits after taking into account the applicable federal, state, local and foreign income, employment and excise taxes (including the Excise Tax). If Covered Payments are reduced, such Covered Payments shall be reduced in a manner that maximizes
the Executive’s economic position. In applying this principle, the reduction shall be made in a manner consistent with the requirements of Section 409A of the Code, to the extent applicable, and where two or more economically equivalent
amounts are subject to reduction but payable at different times, such amounts payable at the later time shall be reduced first but not below zero (0). 

11. Representations. 
 The
parties hereto hereby represent that they each have the authority to enter into this Agreement, and the Executive hereby represents to the Company that the execution of, and performance of duties under, this Agreement shall not constitute a breach
of or otherwise violate any other agreement to which the Executive is a party. 
 12. Miscellaneous. 

(a) Any notice or other communication required or permitted under this Agreement shall be effective only if it is in writing and shall be
deemed to be given when delivered personally or four days after it is mailed by registered or certified mail, postage prepaid, return receipt requested or one day after it is sent by a reputable overnight courier service and, in each case, addressed
as follows (or if it is sent through any other method agreed upon by the parties): 
 If to the Parent: 

Surgical Care Affiliates, Inc. 

Attn: General Counsel 
 569
Brookwood Village, Suite 901 
 Birmingham, AL 35209 

With a copy to: 
 Timothy W.
Gregg 
 Maynard Cooper & Gale, PC 

1901 6th Ave. N. 
 2400
Regions/Harbert Plaza 
 Birmingham, AL 35203 

  
 8 








 If to the Employer: 

Surgical Care Affiliates LLC 

Attn: General Counsel 
 569
Brookwood Village, Suite 901 
 Birmingham, AL 35209 

With a copy to: 
 Timothy W.
Gregg 
 Maynard Cooper & Gale, PC 

1901 6th Ave. N. 
 2400
Regions/Harbert Plaza 
 Birmingham, AL 35203 

If to the Executive: 
 At his
most recent address shown on the payroll records of the Employer 
 or to such other address as any party hereto may designate by notice to the others. 

(b) This Agreement shall constitute the entire agreement among the parties hereto with respect to the matters set forth hereunder, and
supersedes and is in full substitution for any and all prior understandings or agreements with respect to such matters including the Original Agreement except (i) with respect to the Executive’s rights to amounts that are earned and vested
prior to the Effective Date, and (ii) that Section 6(b) shall survive with respect to acts and omissions prior to the Effective Date. 

(c) This Agreement may be amended only by an instrument in writing signed by the parties hereto, and any provision hereof may be waived only
by an instrument in writing signed by the party or parties against whom or which enforcement of such waiver is sought. The failure of any party hereto at any time to require the performance by any other party hereto of any provision hereof shall in
no way affect the full right to require such performance at any time thereafter, nor shall the waiver by any party hereto of a breach of any provision hereof be taken or held to be a waiver of any succeeding breach of such provision or a waiver of
the provision itself or a waiver of any other provision of this Agreement. 
 (d) The parties hereto acknowledge and agree that each party
has reviewed and negotiated the terms and provisions of this Agreement and has had the opportunity to contribute to its revision. Accordingly, the rule of construction to the effect that ambiguities are resolved against the drafting party shall not
be employed in the interpretation of this Agreement. Rather, the terms of this Agreement shall be construed fairly as to both parties hereto and not in favor or against either party. 

(e) This Agreement is binding on and is for the benefit of the parties hereto and their respective successors, assigns, heirs, executors,
administrators and other legal representatives. Neither this Agreement nor any right or obligation hereunder may be assigned by the Executive. 

(f) The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or
substantially all of the business and/or assets of the Company to assume this Agreement in the same manner and to the same extent that the Company would have been required to perform it if no such succession had taken place. As used in the
Agreement, “the Company” shall mean both the Company as defined above and any such successor that assumes this Agreement, by operation of law or otherwise. 

  
 9 








 (g) Any provision of this Agreement (or portion thereof) which is deemed invalid, illegal or
unenforceable in any jurisdiction shall, as to that jurisdiction and subject to this Section, be ineffective to the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions thereof in such
jurisdiction or rendering that or any other provisions of this Agreement invalid, illegal, or unenforceable in any other jurisdiction. If any covenant should be deemed invalid, illegal or unenforceable because its scope is considered excessive, such
covenant shall be modified so that the scope of the covenant is reduced only to the minimum extent necessary to render the modified covenant valid, legal and enforceable. No waiver of any provision or violation of this Agreement by the Company shall
be implied by the Company’s forbearance or failure to take action. 
 (h) The intent of the parties is that payments and benefits under
this Agreement comply with Section 409A of the Code and the regulations and guidance promulgated thereunder (except to the extent exempt as short-term deferrals or otherwise) and, accordingly, to the maximum extent permitted, this Agreement
shall be interpreted to be in compliance therewith. A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits subject to Section 409A of
the Code upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Section 409A of the Code and, for purposes of any such provision of this Agreement, references to
a “termination,” “termination of employment,” “termination of the Employment Period” or like terms shall mean “separation from service.” The determination of whether and when a separation from service has
occurred shall be made in a manner consistent with, and based on the presumptions set forth in, U.S. Treasury Regulation Section 1.409A-1(h) or any successor provision thereto. It is intended that each installment, if any, of the payments and
benefits provided hereunder shall be treated as a separate “payment” for purposes of Section 409A of the Code. Neither the Company nor the Executive shall have the right to accelerate or defer the delivery of any such payments or
benefits except to the extent specifically permitted or required by Section 409A of the Code; and if, as of the date of the “separation from service,” the Executive is a “specified employee” (within the meaning of that term
under Section 409A(a)(2)(B) of the Code, or any successor provision thereto), then with regard to any payment or the provision of any benefit that is subject to this section (whether under this Agreement, or pursuant to any other agreement with
or plan, program, payroll practice of the Company) and is due upon or as a result of the Executive’s separation from service, such payment or benefit shall not be made or provided, to the extent making or providing such payment or benefit would
result in additional taxes or interest under Section 409A of the Code, until the date which is the earlier of (i) the expiration of the six (6)-month period measured from the date of such “separation from service,” and
(ii) the date of the Executive’s death (the “Delay Period”) and this Agreement and each such agreement, plan, program, or payroll practice shall hereby be deemed amended accordingly. Upon the expiration of the Delay
Period, all payments and benefits delayed pursuant to this Section 12(h) (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed to the Executive in a lump
sum, and any remaining payments and benefits due under this Agreement shall be paid or provided in accordance with the normal payment dates specified for them herein. All reimbursements and in-kind benefits provided under this Agreement or otherwise
to the Executive shall be made or provided in accordance with the requirements of Section 409A of the Code to the extent that such reimbursements or in-kind benefits are subject to Section 409A of the Code. All expenses or other
reimbursements paid pursuant herewith and therewith that are taxable income to Executive shall in no event be paid later than the end of the calendar year next following the calendar year in which Executive incurs such expense or pays such related
tax. With regard to any provision herein that provides for reimbursement of costs and expenses or in-kind benefits, except as permitted by Section 409A of the Code, the right to reimbursement or in-kind benefits shall not be subject to
liquidation or exchange for another benefit, the amount of expenses eligible for reimbursement, or in-kind benefits provided, during any taxable year shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in
any other taxable year, provided that, the foregoing clause shall not be violated with regard to 

  
 10 








 
expenses reimbursed under any arrangement covered by Section 105(b) of the Code solely because such expenses are subject to a limit related to the period the arrangement is in effect and
such payments shall be made on or before the last day of Executive’s taxable year following the taxable year in which the expense occurred. 

(i) This Agreement shall be governed by and construed in accordance with the laws of the State of Alabama without reference to its principles
of conflicts of law. 
 (j) This Agreement may be executed in several counterparts, each of which shall be deemed an original, but all of
which shall constitute one and the same instrument. A facsimile of a signature shall be deemed to be and have the effect of an original signature. 

(k) The headings in this Agreement are inserted for convenience of reference only and shall not be a part of or control or affect the meaning
of any provision hereof. 

*    *    *    *    *    * 

  
 11 








 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

			
	SURGICAL CARE AFFILIATES, INC.
	
	 /s/ Richard L. Sharff, Jr.

	Name:		Richard L. Sharff, Jr.
	Title:		Executive Vice President & General Counsel
	
	SURGICAL CARE AFFILIATES LLC
	
	 /s/ Richard L. Sharff, Jr.

	Name:		Richard L. Sharff, Jr.
	Title:		Executive Vice President & General Counsel
	
	EXECUTIVE
	
	 /s/ Tom W. F. De Weerdt

	Tom W. F. De Weerdt



  
 12 








 EXHIBIT A 

Approved Board Positions 
 Advisory Board
of Engaged Health Solutions 

  
 13 








 EXHIBIT B 

SURGICAL CARE AFFILIATES, INC. 

2013 OMNIBUS LONG-TERM INCENTIVE PLAN 

RESTRICTED STOCK UNIT AWARD AGREEMENT 

TIME-VESTING RESTRICTED STOCK UNITS 

This Restricted Stock Unit Award Agreement (this “Agreement”), is entered into as of May 19, 2015 (the “Grant
Date”), by and between Surgical Care Affiliates, Inc., a Delaware corporation (the “Company”), and Tom W. F. De Weerdt, an employee of the Company or one or more of its Subsidiaries (the “Participant”).

 Pursuant to the Surgical Care Affiliates, Inc. 2013 Omnibus Long-Term Incentive Plan, as amended (the “Plan”), the Board
of Directors of the Company (or its Compensation Committee or a designee thereof) has determined that the Participant shall be granted an Incentive Award in the form of restricted stock units (“RSUs”) upon the terms and subject to
the conditions hereinafter contained. Capitalized terms used but not defined herein shall have the meanings assigned to them in the Plan. 

1. Number of Units and Settlement. The Participant is hereby granted
[—] RSUs, subject to the restrictions set forth herein. Each RSU granted hereunder represents the right to receive one share of the Company’s Common Stock on the
Settlement Date (as defined herein), upon the terms and subject to the conditions (including the vesting conditions) set forth in this Agreement and the Plan. The Settlement Date shall occur on each date set forth under Section 4 that the
restrictions on transfer set forth in Section 2(a) shall lapse. 
 2. Terms of Restricted Stock Units. The grant of RSUs
provided in Section 1 hereof shall be subject to the following terms, conditions and restrictions: 
 (a) The RSUs, and any interest
therein, may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than in accordance with the terms of the Plan. 

(b) Notwithstanding any other provision of this Agreement, in no event shall any outstanding restrictions lapse prior to the satisfaction by
the Participant of the liabilities described in Section 7 hereof. 
 (c) The Committee may, in its discretion, cancel all or any part
of any outstanding restrictions prior to the expiration of the periods provided in Section 4 hereof. 
 3. Rights as a
Stockholder. Since the RSUs granted hereunder shall be settled in shares of the Company’s Common Stock, the Participant shall possess all incidents of ownership as to such shares that are transferred to the Participant in respect of the
settlement of the RSUs, including the right to receive or reinvest dividends with respect to such shares (to the extent declared by the Company) and the right to vote such shares. Such incidents of ownership shall commence on each such respective
Settlement Date, and only with respect to such shares that are transferred to the Participant on such Settlement Date. 
 4. Lapse of
Restrictions. Except as may otherwise be provided herein, the restrictions on transfer set forth in Section 2(a) shall lapse: 

(a) with respect to thirty-three and one-third percent (33.33%) of the RSUs, on the first anniversary of the Grant Date; 

  
 14 








 (b) with respect to thirty-three and one-third percent (33.33%) of the RSUs, on the second
anniversary of the Grant Date; and 
 (c) with respect to thirty-three and one-third percent (33.33%) of the RSUs, on the third
anniversary of the Grant Date. 
 Upon each lapse of restrictions relating to the RSUs, and provided that the Participant shall have
complied with the Participant’s obligations under Section 7 hereof, the Company shall issue to the Participant or the Participant’s personal representative one share of Common Stock on the Company’s books and records, in exchange
for each RSU with respect to which such restrictions have lapsed. 
 5. Effect of Certain Changes. In the event the
Participant’s Employment is terminated without Cause within the two (2) year period following the consummation of a Change in Control, all restrictions then outstanding with respect to the RSUs shall automatically expire and be of no
further force and effect, and full payment in respect of the RSUs granted hereunder shall be made as soon as practicable thereafter, and in any event not more than 30 days following such termination of Employment, but only if permissible under
Section 409A of the Internal Revenue Code; if such settlement is not permissible under Section 409A, then settlement shall occur in accordance with the other terms of this Agreement. For purposes hereof, “Cause” shall
mean, unless otherwise provided in an employment agreement in effect immediately prior to such termination, (i) a failure of the Participant to reasonably and substantially perform his or her duties to the Company or any of its Subsidiaries
(other than as a result of physical or mental illness or injury); (ii) the Participant’s willful misconduct or gross negligence; (iii) a breach by the Participant of the Participant’s fiduciary duty or duty of loyalty to the
Company or any of its Affiliates; (iv) the commission by the Participant of any felony or other serious crime; or (v) a breach by the Participant of the terms of any agreement with the Company or any Subsidiary or any Company policies.

 6. Termination of Employment. In the event that the Participant ceases to be Employed by the Company or any of its
Subsidiaries for any reason, all RSUs with respect to which the restrictions set forth in Section 4 hereof shall not yet have lapsed (taking into account Sections 2 and 5) shall thereupon be automatically forfeited by the Participant. 

7. Taxes. The Participant shall pay to the Company promptly upon request, and in any event at the time the Participant
recognizes taxable income in respect of the RSUs, an amount equal to the taxes the Company determines it is required to withhold, if any, under applicable tax laws with respect to the settlement of the RSUs. Such payment shall be made in the form of
cash, shares of Common Stock already owned or otherwise issuable as of the Settlement Date, or in a combination of such methods, subject to the terms of the Plan. In the event the Participant does not promptly pay to the Company an amount equal to
the taxes the Company determines it is required to withhold under applicable tax laws with respect to the settlement of the RSUs, the Company shall offset such amount against any amounts, including shares of Common Stock, owed by the Company to the
Participant, whether under this Agreement or otherwise, to the extent permitted by Section 409A. 
 8. No Guarantee of
Employment. Nothing set forth herein or in the Plan shall (i) confer upon the Participant any right of continued Employment for any period by the Company or any of its Subsidiaries, (ii) entitle the Participant to remuneration or
benefits not set forth in the Plan, or (iii) interfere with or limit in any way the right of the Company or any Subsidiary to terminate such Participant’s Employment. 

  
 15 








 9. Notices. Any notice required or permitted under this Agreement shall be in
writing and deemed given when (i) delivered personally, (ii) mailed by United States certified or registered mail, return receipt requested, postage prepaid, or (iii) delivered by overnight courier service. Such notices shall be sent
to the Participant at the last address specified in the Company’s records (or such other address as the Participant may designate in writing to the Company), or to the Company at the following address (or such other address as the Company may
designate in writing to the Participant): 
 Surgical Care Affiliates, Inc. 

569 Brookwood Village, Suite 901 

Birmingham, AL 35209 
 Attn:
General Counsel 
 10. Failure To Enforce Not a Waiver. The failure of the Company to enforce at any time any provision of
this Agreement shall in no way be construed to be a waiver of such provision or of any other provision hereof. 
 11. Governing
Law. This Agreement shall be governed by and construed according to the laws of the State of Delaware, without regard to its conflict of law principles. 

12. Incorporation of Plan. A copy of the Plan is attached hereto and incorporated herein by reference and made a part of this
Agreement. This Agreement and the RSUs shall be subject to the terms of the Plan, as it may be amended from time to time, provided that such amendment of the Plan is made in accordance with Section 16 of the Plan. 

13. Clawback Policies. Notwithstanding anything in the Plan to the contrary, the Company will be entitled, to the extent
permitted or required by applicable law, Company policy and/or the requirements of an exchange on which the Company’s shares are listed for trading, in each case, as in effect from time to time, to recoup compensation of whatever kind paid by
the Company or any of its Affiliates at any time to a Participant under the Plan and the Participant, by accepting this award of RSUs pursuant to the Plan and this Agreement, agrees to comply with any Company request or demand for such
recoupment.  
 14. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be an
original but all of which together shall represent one and the same agreement. 
  

									
	SURGICAL CARE AFFILIATES, INC.:				PARTICIPANT:
				
	By:		  
				  

	Name:						Tom W. F. De Weerdt
	Title:						  
  

							Date:


  
 16